Resumen
A case of abnormal biodistribution of a bone scanning radiopharmaceutical due to iron dextran therapy is presented, and possible mechanisms are discussed.
Idioma original | English |
---|---|
Páginas (desde-hasta) | 818-820 |
Número de páginas | 3 |
Publicación | Clinical Nuclear Medicine |
Volumen | 15 |
N.º | 11 |
DOI | |
Estado | Published - 1990 |
Publicado de forma externa | Sí |
ASJC Scopus Subject Areas
- Radiology Nuclear Medicine and imaging